Bristol-Myers to Pay $11 Billion to License Cancer Drug
Prior: P: 235.7
New: N: -
Prior: Prior: 235.7
New: New: -
-
Prior: Prior: 6.98
New: New: -
Prior: Prior: 49
New: New: -
Latest News
- Robinhood exec touts retail investor strength, says overnight trading the future
- Elon Musk gets more time to respond to US SEC lawsuit over Twitter stake
- 'Hangover' setting in for automakers with sales poised to go lower
- Daily Spotlight: Argus Adjusts S&P 500 EPS Estimates
- Anduril secures $30.5 billion valuation in latest fund raise
- Why Navitas Semiconductor Rocketed 164% in May